Adios To Alcon In April As Novartis Confirms Spin-Off Date

22 Mar 2019

With the eye-care business set for its own stock exchange listings next month and the future of Sandoz the subject of much discussion, Novartis' plan to be a pure play pharma firm moves ever closer.

Skaters — Time to let go: Alcon to be spun off next month • Source: Shutterstock

Novartis AG has confirmed April 9 as the date when it will spin off the ophthalmology unit Alcon Inc. and continue the Swiss giant's push to be a pure pharma-focused company.

Slightly ahead of some analyst predictions, shares in the eye-care business will start trading on Swiss market and the New...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

HHS mRNA Vaccine Wind-Down Has Limited Impact (And One Contract Isn’t Even mRNA)

06 Aug 2025

• By Alaric DeArment

The news will have a big impact on pandemic preparedness but less immediate financial impact. Tiba Biotech was even “caught off guard” by its inclusion in the department’s culling of mRNA vaccine projects under BARDA, as its project was neither a vaccine nor mRNA-based.